medication-migraine-prevention-eptinezumab-intravenous-quarterly-chronic-generic

Outcomes

01
pain-headache-migraine-disability-midas-monthly-disability-days-count-self-reported
1 evidence row
- starling_2026_cohort_long-term-reductions-in-headache-frequency-severity-and-disability-with-eptinezumab-in-adults-with-chronic-migraine
02
pain-headache-migraine-disability-midas-score-self-reported
1 evidence row
- starling-kudrow-kapur_2026_cohort_long-term-reductions-in-headache-frequency-severity-and-disability-with-eptinezumab-in-adults-with-chronic-migraine-prevail
03
pain-headache-migraine-monthly-frequency-severity-composite-score-self-reported
2 evidence rows
- starling-kudrow-kapur_2026_cohort_long-term-reductions-in-headache-frequency-severity-and-disability-with-eptinezumab-in-adults-with-chronic-migraine-prevail
- starling_2026_cohort_long-term-reductions-in-headache-frequency-severity-and-disability-with-eptinezumab-in-adults-with-chronic-migraine
04
pain-headache-migraine-monthly-headache-days-below-4-days-binary-self-reported
1 evidence row
- starling_2026_cohort_long-term-reductions-in-headache-frequency-severity-and-disability-with-eptinezumab-in-adults-with-chronic-migraine
05
pain-headache-migraine-monthly-headache-days-change-count-self-reported
1 evidence row
- starling_2026_cohort_long-term-reductions-in-headache-frequency-severity-and-disability-with-eptinezumab-in-adults-with-chronic-migraine
06
pain-headache-migraine-monthly-headache-days-count-self-reported
1 evidence row
- starling-kudrow-kapur_2026_cohort_long-term-reductions-in-headache-frequency-severity-and-disability-with-eptinezumab-in-adults-with-chronic-migraine-prevail
07
pain-headache-migraine-monthly-impact-days-family-social-leisure-count-self-reported
1 evidence row
- starling-kudrow-kapur_2026_cohort_long-term-reductions-in-headache-frequency-severity-and-disability-with-eptinezumab-in-adults-with-chronic-migraine-prevail
08
pain-headache-migraine-monthly-impact-days-household-work-count-self-reported
1 evidence row
- starling-kudrow-kapur_2026_cohort_long-term-reductions-in-headache-frequency-severity-and-disability-with-eptinezumab-in-adults-with-chronic-migraine-prevail
09
pain-headache-migraine-monthly-impact-days-work-school-count-self-reported
1 evidence row
- starling-kudrow-kapur_2026_cohort_long-term-reductions-in-headache-frequency-severity-and-disability-with-eptinezumab-in-adults-with-chronic-migraine-prevail

medication-migraine-prevention-eptinezumab-intravenous-quarterly-chronic-generic

Outcomes

pain-headache-migraine-disability-midas-monthly-disability-days-count-self-reported

pain-headache-migraine-disability-midas-score-self-reported

pain-headache-migraine-monthly-frequency-severity-composite-score-self-reported

pain-headache-migraine-monthly-headache-days-below-4-days-binary-self-reported

pain-headache-migraine-monthly-headache-days-change-count-self-reported

pain-headache-migraine-monthly-headache-days-count-self-reported

pain-headache-migraine-monthly-impact-days-family-social-leisure-count-self-reported

pain-headache-migraine-monthly-impact-days-household-work-count-self-reported

pain-headache-migraine-monthly-impact-days-work-school-count-self-reported